Takashi Hayakawa, Takuya Nagashima, Hayato Akimoto, Kimino Minagawa, Yasuo Takahashi, Satoshi Asai. Benzodiazepine-related dementia risks and protopathic biases revealed by multiple-kernel learning with electronic medical records. Digital Health. 2023. 9. 1-23
Hayato Akimoto, Takashi Hayakawa, Takuya Nagashima, Kimino Minagawa, Yasuo Takahashi, Satoshi Asai. Detection of potential drug-drug interactions for risk of acute kidney injury: a population-based case-control study using interpretable machine-learning models. Frontiers in Pharmacology. 2023. 14
Akimoto, H, Nagashima, T, Minagawa, K, Hayakawa, T, Takahashi, Y, Asai, S. Detection of synergistic interaction on an additive scale between two drugs on abnormal elevation of serum alanine aminotransferase using machine-learning algorithms. Frontiers in Pharmacology. 2022. 13
Takuya Nagashima, Takashi Hayakawa, Hayato Akimoto, Kimino Minagawa, Yasuo Takahashi, Satoshi Asai. Identifying antidepressants less likely to cause hyponatremia: triangulation of retrospective cohort, disproportionality, and pharmacodynamic studies. Clinical Pharmacology and Therapeutics. 2022. 111. 6. 1258-1267
Hayato Akimoto, Takuya Nagashima, Kimino Minagawa, Takashi Hayakawa, Yasuo Takahashi, Satoshi Asai. Signal Detection of Potential Hepatotoxic Drugs: Case-Control Study Using Both a Spontaneous Reporting System and Electronic Medical Records. Biological and Pharmaceutical Bulletin. 2021. 44. 10. 1514-1523